JPS61277673A - Novel thiazolidine derivative - Google Patents
Novel thiazolidine derivativeInfo
- Publication number
- JPS61277673A JPS61277673A JP60121127A JP12112785A JPS61277673A JP S61277673 A JPS61277673 A JP S61277673A JP 60121127 A JP60121127 A JP 60121127A JP 12112785 A JP12112785 A JP 12112785A JP S61277673 A JPS61277673 A JP S61277673A
- Authority
- JP
- Japan
- Prior art keywords
- compound
- formula
- expressed
- lower alkyl
- compound expressed
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Thiazole And Isothizaole Compounds (AREA)
Abstract
Description
【発明の詳細な説明】 本発明は新規なチアゾリジン誘導体に関する。[Detailed description of the invention] The present invention relates to novel thiazolidine derivatives.
更に詳しくは本発明は一般式(I)で示されるチアゾリ
ジン誘導体に関する。More specifically, the present invention relates to thiazolidine derivatives represented by general formula (I).
R盲
(式中Rは低級アルキル基を意味し、R2はカルボキシ
ル基の保護基を意味する)
本発明の一般式(I)で示されるチアゾリジン誘導体は
新規化合物であり種々のペナム環を打すする化合物の合
成中間体として何月である。R blind (in the formula, R means a lower alkyl group, R2 means a protecting group for a carboxyl group) The thiazolidine derivative represented by the general formula (I) of the present invention is a new compound and has various penam rings. It is used as an intermediate for the synthesis of compounds.
ペニシリン類等のペナム環を有する化合物の化学的な合
成法としては数多くの方法が知られているが、合成工程
数又は処理操作等の点で工業生産上溝足すべきものは多
くない。Although many methods are known for chemically synthesizing compounds having a penum ring such as penicillins, there are not many methods that are suitable for industrial production in terms of the number of synthesis steps or treatment operations.
本発明者等はペナム環を有する化合物の合成法につき鋭
意研究した結果、本発明の一般式(I)で示されるチア
ゾリジン誘導体が容易に入手できる原料であるシステア
ミン等を出発物質として僅か数工程で製造できること、
および一般式(I)の化合物から容易な手段によりペナ
ム環を有する化合物が得られる方法を見出し更に検討を
加えて本発明を完成した。As a result of intensive research into a method for synthesizing a compound having a penum ring, the present inventors have found that the thiazolidine derivative represented by the general formula (I) of the present invention can be produced in just a few steps using an easily available raw material such as cysteamine as a starting material. What we can manufacture;
They discovered a method for obtaining a penum ring-containing compound from the compound of general formula (I) by easy means, and conducted further studies to complete the present invention.
本発明の一般式(I)で示されるチアゾリジン誘導体は
例えば以下式示するA)お上びB)の2つの方法に従っ
て合成される。The thiazolidine derivative represented by the general formula (I) of the present invention can be synthesized, for example, according to the two methods A) and B) shown below.
(II)
る)
反応式A)の化合物(n)とシステアミンから化合物(
I)を製造する反応および反応式B)の化合物(In)
とシステアミンから化合物(I)を製造する反応は、は
ぼ同様であり、不活性溶媒中撹拌することにより容易に
行われる。なおシステアミンの酸塩、例えば塩酸塩を原
料として用いる場合は塩基、例えばトリエチルアミン等
の有機塩基の存在下に反応せしめるのが好ましい。(II) From compound (n) of reaction formula A) and cysteamine, compound (
Reaction for producing I) and compound (In) of reaction formula B)
The reaction for producing compound (I) from and cysteamine is similar to that described above, and is easily carried out by stirring in an inert solvent. Note that when an acid salt of cysteamine, such as hydrochloride, is used as a raw material, it is preferable to react in the presence of a base, such as an organic base such as triethylamine.
本発明の一般式(I)で示される化合物において、Rt
で示される低級アルキル基としては、例えば炭素数1乃
至3のアルキル基であり、具体的にはメチル基、エチル
基、プロピル基等である。In the compound represented by the general formula (I) of the present invention, Rt
The lower alkyl group represented by is, for example, an alkyl group having 1 to 3 carbon atoms, and specifically, a methyl group, an ethyl group, a propyl group, etc.
R2で示されるカルボキシル基の保護基としては、前記
A)またはB)の反応に際し不活性なものであればよく
特に制限はないが、通常はメチル基、エチル基等の低級
アルキル基である。The protecting group for the carboxyl group represented by R2 is not particularly limited as long as it is inert during the reaction A) or B), but it is usually a lower alkyl group such as a methyl group or an ethyl group.
本発明の一般式(I)で示される化合物は容易に一般式
(fV)で示されるペナム環を有する化合物に8導され
る。The compound represented by the general formula (I) of the present invention is easily converted into a compound having a penum ring represented by the general formula (fV).
(式中R1は前記と同じものを意味する)一般式(I)
で示される化合物から一般式(■)で示される化合物の
製造は、例えば一般式(I)を濃塩酸を用いる加水分解
反応に付し5−低級アルキルー7−オキソー4−チア−
1−アザビシクロ [3,2,0) へブタン類の塩
酸塩にした後、このものを単離精製することなくアセト
ニトリル中トリフェニルホスフィンと2,2−ジピリジ
ルジスルフィドで処理することにより行われる。(In the formula, R1 means the same as above) General formula (I)
The compound represented by the general formula (■) can be produced from the compound represented by, for example, by subjecting the general formula (I) to a hydrolysis reaction using concentrated hydrochloric acid to form 5-lower alkyl-7-oxo-4-thia-
This is carried out by converting 1-azabicyclo[3,2,0)hebutane into a hydrochloride salt, and then treating this product with triphenylphosphine and 2,2-dipyridyl disulfide in acetonitrile without isolation and purification.
この一般式(rV)で示される化合物はそれ自体安定で
ある。またそのペナム環の6位は種々の反応に対して活
性であり種々の置換基を導入することができ、他のペニ
シリン類の合成中間体としても用いることができる。The compound represented by this general formula (rV) is itself stable. Furthermore, the 6-position of the penam ring is active in various reactions and various substituents can be introduced therein, and it can also be used as a synthetic intermediate for other penicillins.
以下に実施例を挙げて更に具体的に本発明を説明する。EXAMPLES The present invention will be explained in more detail by giving examples below.
化合物(1)0.981g(0,01モル)システアミ
ン 1.138g(0,01モル)およびトリエチルア
ミン1. Olg(0,01モル)をメタノール30m
1中室温で20時間攪拌する。溶媒を留去した後、残渣
をシリカゲルカラムクロマトグラフィー(ヘキサン−酢
酸エチル5:1)に付し精製し化合物(2)1.02g
を得る。Compound (1) 0.981 g (0.01 mol) cysteamine 1.138 g (0.01 mol) and triethylamine 1. Olg (0.01 mol) in methanol 30m
Stir in 1 at room temperature for 20 hours. After distilling off the solvent, the residue was purified by silica gel column chromatography (hexane-ethyl acetate 5:1) to obtain 1.02 g of compound (2).
get.
マススペクトルm/z : 175(M )、16
0IRスペクトル (CHCI ):3480,17
30cm−’NMRスペクトル (CDCI )δ
: 1.85 (3H。Mass spectrum m/z: 175 (M), 16
0IR spectrum (CHCI): 3480,17
30cm-'NMR spectrum (CDCI) δ
: 1.85 (3H.
s) 、2.49 (IH+ brs)+ 2.
88 (2H+ s) 。s), 2.49 (IH+brs)+2.
88 (2H+s).
2.93〜3.57 (4H,m)、3.71 (3H
,s)実施例2゜
化合物(3)2.32g(0,02モル)、システアミ
ン塩酸塩2.27g(0,02モル)、トリエチルアミ
ン2.02g(0,02モル)およびメタノールθOm
lを用い、以下実施例1と同様に処理し化合物(2)2
.98gを得る。このものの物性値は実施例(1)で得
たものと一致した。2.93-3.57 (4H, m), 3.71 (3H
,s) Example 2゜ Compound (3) 2.32 g (0.02 mol), cysteamine hydrochloride 2.27 g (0.02 mol), triethylamine 2.02 g (0.02 mol) and methanol θOm
Compound (2) 2 was prepared in the same manner as in Example 1 using
.. Obtain 98g. The physical properties of this product were consistent with those obtained in Example (1).
化合物(4)2.803g(0,02モル)、システア
ミン塩酸塩2.272g(0,02モル)、トリエチル
アミン 2.02g(0,02モル)およびメタノール
50m1を用い、以下実施例1と同様に処理し化合物(
5) 2.E35gを得る。The following procedure was carried out in the same manner as in Example 1 using 2.803 g (0.02 mol) of compound (4), 2.272 g (0.02 mol) of cysteamine hydrochloride, 2.02 g (0.02 mol) of triethylamine and 50 ml of methanol. Treated compounds (
5) 2. Obtain 35 g of E.
マススペクトルm/z : 189(M )、18
01Rスペクトル (CHCI3):3340−173
0cmNMRスペクトル (CDCI )δ :
0.99(3H。Mass spectrum m/z: 189 (M), 18
01R spectrum (CHCI3): 3340-173
0cm NMR spectrum (CDCI) δ:
0.99 (3H.
t)、 t、 92(2H,Q)、 2.83(IH
,brs)。t), t, 92(2H,Q), 2.83(IH
,brs).
2、77〜3.53 (4H,m) 、 2.83
(2H,s) 。2,77~3.53 (4H,m), 2.83
(2H,s).
参考例1
実施例(1)で得た化合物(2) 0.584 g(
3,33モル)に水冷下1塩酸10m1を滴下し、その
まま30分間攪拌する。次いで水5mlを滴下し、室温
で12時間攪拌する。塩酸水溶液を20″C以下で減圧
留去し、得られる残渣を精製することなく次の反応に付
す。Reference Example 1 Compound (2) obtained in Example (1) 0.584 g (
3.33 mol) was added dropwise with 10 ml of 1-hydrochloric acid under water cooling, and the mixture was stirred for 30 minutes. Then, 5 ml of water is added dropwise, and the mixture is stirred at room temperature for 12 hours. The aqueous hydrochloric acid solution is distilled off under reduced pressure below 20"C, and the resulting residue is subjected to the next reaction without purification.
トリフエルホスフィン 1.049g(3,99ミリモ
ル)、2.2−ジピリジルジスルフィド o、sstg
(3,99ミリモル)および前記の残渣のアセトニトリ
ル330m1 溶液にトリエチルアミン0゜370g
(3,87ミリモル)を加え室温で3時間攪拌する。溶
媒を留去後、残渣をシリカゲルカラムクロマトグラフィ
ーに付し精製し化合物(8)0、144gを得る。Triphelphosphine 1.049 g (3,99 mmol), 2,2-dipyridyl disulfide o, sstg
(3,99 mmol) and a solution of the above residue in 330 ml of acetonitrile was added 0.370 g of triethylamine.
(3.87 mmol) and stirred at room temperature for 3 hours. After distilling off the solvent, the residue was purified by silica gel column chromatography to obtain 0.144 g of compound (8).
マススペクトルm/z :143(M )、115.
1011Rスペクトル (CHCI ): 176
5cm−’NMRスペクトル (CDCI )δ :
1.7g (3H。Mass spectrum m/z: 143 (M), 115.
1011R spectrum (CHCI): 176
5cm-'NMR spectrum (CDCI) δ:
1.7g (3H.
s)、2.84〜3.40 (3H,m)、 3.
2E3 (2H。s), 2.84-3.40 (3H, m), 3.
2E3 (2H.
s)、 4.13(IH,ddd、J= 3.8
. 5.8゜11.4Hz)
参考例2゜
実施例3で得た化合物(5)0.5g 、 a塩酸1
0m1 および水3ml を用い参考例1と同様に
加水分解した後、トリフェニルホスフィン0.832g
(3,17ミリモル)、2.2−ジピリジルジスルフィ
ド、 0.698g (3,17ミリモル)、トリエチ
ルアミン0.291g (2,88ミリモル)およびア
セトニトリル284ml を用い参考例■と同様に処理
し化合物(7) 0.087g 78る。s), 4.13 (IH, ddd, J = 3.8
.. 5.8゜11.4Hz) Reference Example 2゜Compound (5) obtained in Example 3 0.5g, a Hydrochloric acid 1
After hydrolyzing in the same manner as in Reference Example 1 using 0ml and 3ml of water, 0.832g of triphenylphosphine
The compound (7 ) 0.087g 78ru.
マススペクトルm/z :157(M )、129.
115IRスペクトk (CHCI ): 17
85cm−’NMRスペクトル (CDCI )δ
: 1.05 (3H。Mass spectrum m/z: 157 (M), 129.
115IR spectrum k (CHCI): 17
85cm-'NMR spectrum (CDCI) δ
: 1.05 (3H.
t)+ 1.99(2H,q)、 2.80〜3
.52 (3H。t) + 1.99 (2H, q), 2.80~3
.. 52 (3H.
m)、 3.19 (2H,s)、4.14(IH
,ddd。m), 3.19 (2H, s), 4.14 (IH
,ddd.
Claims (1)
キシル基の保護基を意味する)で示される化合物。[Claims] A compound represented by the general formula ▲ Numerical formula, chemical formula, table, etc. ▼ (In the formula, R_1 means a lower alkyl group, and R_2 means a protecting group for a carboxyl group).
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP60121127A JPS61277673A (en) | 1985-06-04 | 1985-06-04 | Novel thiazolidine derivative |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP60121127A JPS61277673A (en) | 1985-06-04 | 1985-06-04 | Novel thiazolidine derivative |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS61277673A true JPS61277673A (en) | 1986-12-08 |
Family
ID=14803546
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP60121127A Pending JPS61277673A (en) | 1985-06-04 | 1985-06-04 | Novel thiazolidine derivative |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS61277673A (en) |
-
1985
- 1985-06-04 JP JP60121127A patent/JPS61277673A/en active Pending
Non-Patent Citations (1)
Title |
---|
JOUNAL OF MADICINAL CHEMISTRY=1973 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS61277673A (en) | Novel thiazolidine derivative | |
US3910958A (en) | Process for preparing arylacetic acids and esters thereof | |
JP2867847B2 (en) | Method for producing 5-methylene-1,3-dioxolan-4-ones | |
JPH05286894A (en) | New production of carboxylic acid ester or carboxylic acid thioster | |
JPH01233255A (en) | Cyclopentenone derivative and production thereof | |
JP3019528B2 (en) | Process for producing β-lactone and macrocyclic ketone | |
US6921832B2 (en) | Optically active fluorine-containing compounds and processes for their production | |
JPS61200977A (en) | Novel thiazolidine derivative | |
WO2004076391A1 (en) | Process for producing optically active compound | |
JP4524845B2 (en) | Method for producing optically active allyl alcohol derivative having amino group, and optically active compound | |
JP4064645B2 (en) | New production method of polysubstituted cycloalkenes | |
JPS61204189A (en) | Production of novel compound having penam ring | |
JPS63211264A (en) | Production of indolines | |
JPH03178973A (en) | Production of isocumarins | |
JP2718715B2 (en) | 9,10-seco-cycloartane derivatives | |
CN115710213A (en) | Preparation method of cis-chiral 3-fluoro-4-hydroxypiperidine and derivatives thereof | |
CN112778198A (en) | Synthesis method of dihydroquinolinone compound | |
JPS5978196A (en) | Sym-dimethyl di-tert-butyldichlorodisilane | |
CN116987077A (en) | Synthetic method of 2, 3-dihydro indolizine compound | |
KR0140323B1 (en) | PROCESS FOR PREPARING OPTICAL ACTIVE Ñß-AMINOACID | |
KR100645373B1 (en) | Tricyclic tetrahydrofuran lactone derivatives, and process for preparing them | |
JPH02282376A (en) | Production of cis-7-decen-4-olide | |
JPS59163370A (en) | Preparation of 0-(aminomethyl)phenylacetic lactam | |
JPS5936633B2 (en) | Production method of benzocoumarin derivatives | |
KR20030025394A (en) | Preparing Method for N-[3-{3-(1-Piperidinylmethyl)phenoxy}propyl]acetoxyacetamide |